CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study by Kang, Ju-Hee, Mollenhauer, Brit, Coffey, Christopher S., Toledo, Jon B., Weintraub, Daniel, Galasko, Douglas R., Irwin, David J., Van Deerlin, Vivianna, Chen-Plotkin, Alice S., Caspell-Garcia, Chelsea, Waligórska, Teresa, Taylor, Peggy, Shah, Nirali, Pan, Sarah, Zero, Pawel, Frasier, Mark, Marek, Kenneth, Kieburtz, Karl, Jennings, Danna, Tanner, Caroline M., Simuni, Tanya, Singleton, Andrew, Toga, Arthur W., Chowdhury, Sohini, Trojanowski, John Q., Shaw, Leslie M.

Get full text

Limited sampling strategy to predict free mycophenolic acid area under the concentration–time curve in paediatric patients with nephrotic syndrome by Sobiak, Joanna, Żero, Paweł, Zachwieja, Jacek, Ostalska‐Nowicka, Danuta, Pawiński, Tomasz

Get full text

Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study by Sobiak, Joanna, Resztak, Matylda, Pawiński, Tomasz, Żero, Paweł, Ostalska-Nowicka, Danuta, Zachwieja, Jacek, Chrzanowska, Maria

Get full text

Development and Bio-Predictive Evaluation of Biopharmaceutical Properties of Sustained-Release Tablets with a Novel GPR40 Agonist for a First-in-Human Clinical Trial by Juszczyk, Ewelina, Kisło, Kamil, Żero, Paweł, Tratkiewicz, Ewa, Wieczorek, Maciej, Paszkowska, Jadwiga, Banach, Grzegorz, Wiater, Marcela, Hoc, Dagmara, Garbacz, Grzegorz, Sczodrok, Jaroslaw, Danielak, Dorota

Get full text

Theoretical comparison of molecular properties of linear and cyclic glycine derived peptides and their phosphor analogues by Żero, Paweł, Pluciński, Franciszek, Mazurek, Alexander P.

Get full text

Structure in solid state of 3,3′-diindolylmethane derivatives, potent cytotoxic agents against human tumor cells, followed X-ray diffraction and 13C CP/MAS NMR analyses by Maciejewska, Dorota, Wolska, Irena, Niemyjska, Maria, Żero, Paweł

Get full text